Skip to main content

Research Studies

Center for Pediatric Inflammatory Bowel Disease Research Studies

Find research studies available to children cared for by the Center for Pediatric Inflammatory Bowel Disease team.

Appointments and referrals

Clinical Trial Phases

Studying the Clinical Course of Risankizumab

Risankizumab is a medication used for the treatment of Crohn's Disease in adults and children to limit symptoms of the disease. However, as children differ more than adults in their age/weight range and the way that drugs move around their body, more information is needed to understand the factors that might affect the response to the drug in children. 

Phase: N/A

Actively recruiting: Yes

Category: Children, Healthy Controls

VEDOKIDS

This study aims to prospectively explore the real life short and longer term outcomes of Vedolizumab in pediatric inflammatory bowel disease and to develop a prediction model for treatment success based on Vedolizumab trough levels and other clinical and laboratory markers. Children under 18 years of age that have been diagnosed with IBD and their physician is starting treatment with Vedolizumab may be eligible.

Phase: N/A

Actively recruiting: No

Category: Children

Jump back to top